A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs ...

The World Health Organisation, WHO, has warned of a rising cancer burden. Breast cancer remains the most common cancer among ...

AI tools like the ones being tested in the EDITH trial could help facilitate the screening process, allowing the NHS to ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects ...

ROCHESTER, Minn. - According to the National Cancer Institute, an estimated two million new cases of cancer were diagnosed ...

The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five ...

It’s the first time I’ve worn a suit in four years,” Smiley said. “We haven’t worn suits in four years, since post COVID, so it’s kind of fun to say ...

Nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge AI tools can be used to catch breast cancer cases earlier, the Department of Health and Social ...

Hyderabad surpassed other major metropolitan cities in terms of AAR, including Chennai (42.2), Bengaluru (40.5), Delhi (38.6), Mumbai (34.4), ...

Novartis’ Kisqali (ribociclib) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat a ...